28 November 2024
New report reveals how groundbreaking research at the Campus is delivering major gains for UK economic growth and job creation.
12 November 2024
Babraham Research Campus Ltd is delighted to announce the appointment of Dr Louise Jopling to the newly created role of Chief Scientific & Innovation Officer.
11 November 2024
11 November 2024
11 November 2024
31 October 2024
24 October 2024
22 October 2024
16 October 2024
Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded £1.5 million in funding to support clinical validation of Proteotype’s novel Enlighten® Multi-Cancer Early Detection test.
14 October 2024
LoQus23 Therapeutics Ltd (“LoQus23”), a private biotechnology company investigating small molecule drugs that could stop DNA instability and slow neurodegeneration in Huntington’s Disease, myotonic dystrophy type 1 and similar triplet repeat expansion diseases, today announces the successful close of its £35 million (c.$43 million) Series A financing.
14 October 2024
LinkGevity, an AI-driven drug discovery company focused on longevity and age-related disease, has been selected to receive a highly competitive Women TechEU grant. Women TechEU is a project funded through Horizon Europe, the EU’s flagship research and innovation funding program.
14 October 2024
Two of our companies on site have successfully completed a collaboration to assess small molecules identified from an initial cheminformatics drug screen in a bespoke cell-based assay developed by RxCelerate on one of PlaqueTec’s targets discovered in pilot studies.
14 October 2024
Huge congratulations to Campus company RXCelerate for featuring in the JPMorgan & Beauhurst 2024 Report for the top 200 women powered businesses.
14 October 2024
Expression Edits have been named in Labiotech as one of 10 start-ups to watch in 2024.
14 October 2024
bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, announced its comprehensive program for Neuroscience 2024, the annual meeting of the Society for Neuroscience (SfN).
09 October 2024
A large team from across the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK Government’s new research funding agency.
26 September 2024
The timely availability of space at Babraham Research Campus presents an immediate opportunity for ambitious life science ventures, explore more here…
29 May 2024
Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected.
25 March 2024
Mission Therapeutics announces it has raised £25.2 million to progress the clinical development of its drug candidates.
12 February 2024
BugBiome, a biotech harnessing nature’s microbial defences for pest protection to benefit human and planet health, has successfully closed a pre-seed funding round, securing £310k from Cambridge Angels and Discovery Park Ventures.
02 February 2024
Maxion Therapeutics announced today that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to its next phase of development.
23 January 2024
PlaqueTec and the Babraham Institute today announced a collaboration to develop a cell phenotyping assay to detect cell subpopulations in human blood.
07 December 2023
Our partner, Eastern AHSN has become Health Innovation East. As of 1 October 2023, the government and NHS England announced their intention to relicense the 15 Academic Health Science Networks (AHSNs) in England as Health Innovation Networks.
28 November 2023
It was great to see Kathryn being interviewed live on the Business Programme of Sky News with Ian King, representing the Life Science sector.
20 November 2023
Founders at the University of Cambridge opens applications to its first pre-seed accelerator.
20 November 2023
Babraham Research Campus Ltd CEO Derek Jones, BioMed Realty’s Colleen O’Connor, and JLL’s Chris Walters join Montfort’s Andrew Teacher to discuss the outlook for life sciences, the challenges of creating high-spec lab space, and why the success of the industry should be cause for optimism in the UK.
14 November 2023
ViaNautis Bio, a groundbreaking nanomedicine company at the forefront of genetic therapies, is excited to announce the successful completion of its Series A funding round, raising $25 million (£20 million).
18 October 2023
BioMed Realty has completed the lease-up of a 34,000 square feet purpose-built, fully fitted wet laboratory building on the Babraham Research Campus ahead of scheduled completion.
22 September 2023
The Babraham Investor Conference 2023 (BIC) saw more than 150 company founders, investors and industry leaders come together at Babraham Research Campus yesterday, Thursday 21st September.
22 September 2023
Today, Maxion Therapeutics announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors.
21 September 2023
Cementing its position as one of the best places to start-up and scale-up a life sciences venture in Europe, Babraham Research Campus today announced the launch of its new LiveLabs initiative.
13 September 2023
With the aim of encouraging collaborations within the Babraham Research Campus community, the inaugural BioBabraham Symposium, held earlier this summer, saw speakers from across the site present the remarkable scientific innovation taking place on Campus.
21 August 2023
Babraham Research Campus and Global proptech leader Equiem have announced a partnership that will provide an enhanced experience for the Campus’s life science community in Cambridge.
04 August 2023
The cohort of 2023 present findings and next steps to an invited audience at the Babraham Research Campus.
31 July 2023
The BioBabraham Symposium, which took place on Tuesday 18th July, saw the launch of three new initiatives for the Campus community to foster partnerships, including funding for new collaborations.
25 July 2023
Crescendo Biologics, a clinical stage immuno-oncology company based in Cambridge, has taken its funding to date to almost $150 million with a fresh $32 million raise from global investors.
13 July 2023
F-star Therapeutics today announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda.
12 June 2023
Babraham Research Campus Ltd (BRC), the organisation which oversees the development and day-to-day management of the Babraham Research Campus is delighted to welcome Charlie Foreman to the Board as non-executive director.
22 May 2023
Congratulations to our Campus companies at the recent Cambridge Independent Science + Technology Awards.
19 May 2023
Wondering why the grassland hasn't been mowed recently? It's all part of our ecology plan...read on.
16 May 2023
Accelerate@Babraham, the Babraham Research Campus’ programme supporting early-stage life science ventures, announces new cohort.
16 May 2023
Studio Lambert Casting has reached out to Babraham Research Campus in search for some new cast members for their long running television show Gogglebox.
20 April 2023
Biotechnology company Maxion Therapeutics announces it has been awarded a prestigious GBP £2 million grant from Innovate UK, as part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition.
20 April 2023
The IUCT-Oncopole is launching an ambitious national project in collaboration with Artios Pharma Limited.
12 April 2023
The facility will act as the new R&D site for CHARM Therapeutics, providing the Company with the necessary capacity to support its growth plans as it continues to develop its transformational oncology pipeline.
11 April 2023
F-star in Cambridge – an invoX company – has entered into a second licence agreement with Takeda, the Japanese multinational pharma business, for a novel next-generation immuno-oncology bispecific antibody.
06 April 2023
Explore the world-class science and technology facilities of Cambridge in one shot...
17 March 2023
F-star Therapeutics has been acquired by invoX Pharma Limited for $161million.
08 March 2023
I am writing to tell you that we plan to carry out essential maintenance on the A11 between Babraham and Six Mile Bottom. This will involve safety barrier replacement, resurfacing and renewal of signs. This will ensure the A11 continues to remain in a safe and serviceable condition.
03 March 2023
So who was Lt. Berge and why would we put his name on a building? Read on to find out.
27 February 2023
Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced today it has completed a seed investment round, raising over £500K GBP to further enable its pioneering research.
21 February 2023
The next round of the BBSRC ICURe is now live! Applications close on Monday 27th March.
20 February 2023
Places are available to attend a one- day ROSPA CoSHH course to be held at The Babraham Research Campus
15 February 2023
Biotechnology company Maxion Therapeutics (‘Maxion’) today announced the completion of its USD $16 million (GBP £13 million) Series A financing.
13 February 2023
At bit.bio, we are passionate about engineering human cells that will enable the medicines of the future.
13 February 2023
Adrestia Therapeutics has co-founded a research consortium to find new treatments for a potentially fatal disease.
02 February 2023
An exciting research collaboration ‘sprint’ is getting ready to launch on the Babraham Research Campus to better understand the role of an essential cellular process in brain health.
20 January 2023
Work will be starting soon to connect the active travel path at Hildersham East, from the junction with the Hildersham High Street, to link up to the existing Linton Greenway at Dalehead Foods along the A1307. The works will commence in early February for approximately 16 weeks.
20 January 2023
The StartUp Awards recognises the achievements of those amazing individuals who have had a great idea, spotted the opportunity and taken the risks to launch a new product or service.
20 January 2023
Do you want to see your business' hard work recognised? Has your success sky-rocketed this year? Enter before the deadline on January 27
13 January 2023
As part of Kathryn's focus to on identifying and delivering support for companies on Campus across all stages of growth, we met with Campus CEOs to get your views.
10 January 2023
The Babraham Research Campus is delighted to confirm BioMed Realty’s support for its Accelerate@Babraham bio-incubator programme.
06 January 2023
Dr Kathryn Chapman is relishing the challenges she has taken on as she steps into the new role of director, science and entrepreneurship at Babraham Research Campus.
05 January 2023
Alchemab Therapeutics awarded £1.7m from Innovate UK to develop Huntington’s disease therapy towards human trials
29 December 2022
The fundraising will see Qkine, an A@B alumni, move to a new HQ
23 December 2022
BRCL has undergone a review of its current clinical waste streams and wishes to make some improvements, read on to find out more.
20 December 2022
o2h technology specializes in developing MVPs, custom products and special project builds covering web, mobile and cloud. Due to a cancellation of some work, the O2 tech team have space to do a project at cost/not for profit for a start-up that needs their support.
09 December 2022
Everyone living in Greater Cambridge can have their say on the Making Connections proposals - read on to see the new interactive bus map, to see how your journey to work could be impacted by more frequent bus services.
23 November 2022
RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery company Methuselah Health UK Ltd for an undisclosed sum.
21 November 2022
Babraham Research Campus Ltd is delighted to announce the appointment of Dr Kathryn Chapman to the newly created role of Director, Science & Entrepreneurship.
18 November 2022
My STEMM Future is a collaboration between Wellcome Connecting Science, scientists at the Wellcome Genome Campus and The Youth STEMM Award.
11 November 2022
Up to £25k of funding and training is available for researchers, PhD students and technicians. Find out more.
09 November 2022
Aimed at aspiring entrepreneurs and first-time CEO's looking for advanced practical advice, support and feedback.
07 November 2022
Find out when the Campus closes for Christmas and what services will be available.
03 November 2022
Adrestia Therapeutics announced the appointment of Dr James Osborne as Head of Chemistry and the initiation of a multi-target partnership with Proteros biostructures GmbH (Munich, Germany).
02 November 2022
Two new members have been welcomed to bit.bio’s independent ethics and sustainability board to further support the company’s commitment to being a purpose-led, ethical organisation.
31 October 2022
Babraham Research Campus Ltd and the Babraham Institute have secured funding for fifteen PhD studentships from UKRI-BBSRC as part of a Collaborative Training Partnership (CTP).
21 October 2022
Located in the Bennet building, Signatures Cafe will reopen as a self-service facility.
19 October 2022
Babraham Research Campus along with Cambridge Biomedical Campus and Granta Park are coming together to form a group of like-minded people who enjoy a good singalong.
19 October 2022
Please be aware of the forthcoming Royal Mail Strikes. Click here for dates.
12 October 2022
BI are looking for mentors from campus companies to mentor researchers and PhD students.
10 October 2022
Lonza is sharing a series of five educational, free webinars entitled “ Expert Series: Road to First in Human” designed to help early-stage biotechs de-risk development projects, accelerate approval, maximise molecule values and simplify development.
03 October 2022
BioMed Realty is expanding its footprint at the Babraham Research Campus following the formation of a joint venture with Babraham Research Campus to deliver a 40,000 square foot purpose-built building with new fitted laboratory space.
15 September 2022
As a mark of respect, Babraham Research Campus Limited will be closed on Monday 19th September, the day of the Queen’s funeral.
07 September 2022
Matt Antrobus our Head of Estates, will be walking around the Campus with a Waste Auditor tomorrow. They will be visiting buildings and tenanted areas, selected at random, and potentially looking to ask some questions of tenants about what clinical/hazardous wastes are being produced and how waste is segregated.
05 September 2022
Babraham Research Campus tenants* can now claim 10% discount off ANY of Nature’s 90+ other journals.
01 August 2022
Further to Planning Permission granted at the end of last year, we are now able to commence work on B960; the new building located directly South of B940 and B950.
28 July 2022
Feel free to enjoy the new deck chairs, located on the back lawn and beside Minerva
20 July 2022
In 2022/23, this UKRI-BBSRC fund awarded to Babraham Research Campus Ltd, will support five collaborative research projects each worth up to £30,000.
20 July 2022
The Estates team have seasoned firewood available for sale, produced from timber sourced on-site, which arises from tree surgery works around the campus, as well as from our Woodland Conservation Programme.
30 June 2022
We were delighted to welcome over 70 investors back to the Campus for the Investor Conference, which was also streamed online to over 50 viewers.
30 June 2022
Hear how the demand profile of life science companies changes as their businesses mature, and how real estate decisions are now primarily based on the desires and needs of employees in the post-pandemic world.
24 June 2022
Kathryn Corzo took up the role of chief operating officer (COO) at synthetic biology company bit.bio in November.
23 June 2022
Transine Therapeutics today announced the appointment of Andy Billinton as Chief Scientific Officer as it triples its facility footprint at The Babraham Research Campus.
09 June 2022
The Board of Trustees is delighted to announce that Dr Simon Cook has been appointed as the Institute’s Director.
01 June 2022
Five Cambridge companies have made it to the inaugural Growth Index, a ranking of the fastest growing companies in the UK based on a rigorous financial analysis of the compound annual growth of 32,000 companies.
23 May 2022
There’s a fresh new look to the Babraham Institute’s website, click here to see the lighter, brighter and improved digital experience.
19 May 2022
Cambridge biotech pioneer Alchemab Therapeutics has been chosen by US tech giant NVIDIA to harness the power of the UK’s most powerful supercomputer, Cambridge-1.
17 May 2022
Discount at CambsCuisine for all Babraham Research Campus staff
17 May 2022
Why are plants so good for us in our workspace? The Good Plant Company can tell us why, including how you can work with them to improve your office.
17 May 2022
Major work has just been completed the river to improve habitat for wildlife, provide a better view of the river for walkers and improve the ability of the river to cope with floods and droughts.
12 May 2022
Delighted to see so many companies and Accelerate at Babraham alumni being recognised at the recent awards ceremony.
12 May 2022
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed three new hires to its commercial team.
11 May 2022
A new disease model – one of the first of its kind to be made commercially available – is being hailed as a key pathfinder in reflecting the genetics of Huntington’s disease.
05 May 2022
Life science power player Abzena, whose global headquarters is at Babraham Research Campus in Cambridge, has added a sixth site to its global operations network with expansion in California.
05 May 2022
The BBSRC have released an £11m grant fund to support established research partnerships between business and academic institutions.
03 May 2022
Whitecap Consulting has been appointed by The Open University to research and analyse workforce skills and associated requirements in the growing Life Sciences sector in the Oxford-Cambridge Arc to 2030.
28 April 2022
Exclusive discount offer for Babraham Research Campus tenants to the world-famous scientific journal Nature.
28 April 2022
James Seppala and Tim Schoen discuss BioMed Realty’s footprint in the UK and the opportunity in the life sciences real estate market in the years ahead.
25 April 2022
Cambridge is playing a lead role in developing technology designed to rejuvenate skin cells and arrest the march of age-related diseases.
19 April 2022
A new approach to tackling genetic diseases could unlock treatments to some of the most intractable conditions, it is hoped.
08 April 2022
Research from the Babraham Institute has developed a method to ‘time jump’ human skin cells by 30 years, turning back the ageing clock for cells without losing their specialised function.
04 April 2022
The latest cohort of five life science start-ups to complete the 2021/22 cycle of Accelerate at Babraham may have had the added pressure of a pandemic throughout the five-month programme but all made great strides to develop their business propositions, which in turn promises to change patient outcomes.
24 March 2022
Alchemab Therapeutics has been selected by NVIDIA to harness the power of the UK’s most powerful supercomputer, Cambridge-1.
03 March 2022
A community forest garden full of edible plants is being created within the estate of Babraham Research Campus, thanks to council funding and the work of volunteers.
21 February 2022
The longevity biotech company using machine learning to develop therapeutics for safe cellular reprogramming has three open positions.
25 January 2022
The Babraham Research Campus – one of the UK’s leading locations supporting early-stage bioscience enterprise – has been given the go ahead to expand, to ensure the UK life science research and development sector can continue to deliver world-changing health solutions.
21 January 2022
Redesigning PhD training will help develop commercially savvy researchers, address skills gaps in UK bioscience and bolster innovation, say Simon Cook and Derek Jones.
19 January 2022
Entries for the awards close on Friday 21 January!
04 November 2021
Sphere Fluidics has closed a $40million (around £30m) investment round to expand its international sales activities.
29 October 2021
An interview with Steve Jackson, Founder and former CSO of Mission Therapeutics; Founder, CSO and Interim CEO of Adrestia Therapeutics.
25 October 2021
Transatlantic biotech game-changer Bicycle Therapeutics is wowing NASDAQ with its 12-month performance and fundraising magic.
15 October 2021
Robin Bannister, TRx Biosciences’ CEO, said Cipla chairman Dr Yusuf Hamied is “a super investor to have on board” at the launch of TRx Biosciences on Babraham Research Campus yesterday.
14 October 2021
Mission Therapeutics announced today that it has been awarded a Therapeutic Pipeline Program grant of approximately 0.5M USD from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
24 September 2021
The supportive and inclusive collaboration will provide new opportunities for STEMM students and improve employment prospects.
24 September 2021
The lives of millions of women around the world could be improved by extraordinary microbiome editing technology pioneered by synthetic biology start-up CC Bio.
08 September 2021
Exciting progress has been made in the lab in the fight against Huntington’s disease. Scientists at the University of Cambridge and UCL have identified a mechanism that stops its progression in cells.
26 August 2021
Would you like to be a part of the first ever Venture Creation: Sustainability cohort. Participation in the programme will help delegates develop their capacity for future innovation in addition to an entrepreneurial mindset that will support them throughout their career choices.
26 August 2021
Judge Business School are delighted to announce Ignite Founder's Challenge starting in the Autumn term - is now open for applications. A specially designed four-week online programme for early-stage startups that consists of workshops and coaching sessions to transform your idea into a reality.
26 August 2021
Judge Business School have an exciting opportunity for inventors. Would you like to find out if your early-stage research results or new or novel technology has commercial potential? Applications are open to submit project proposals for student teams to work on. The deadline for submissions is 6th September 2021.
15 July 2021
Our CEO, Derek Jones speaks to UKSPA’s BreakThrough magazine about the history, evolution and achievements of the life sciences’ community at the Babraham Research Campus.
15 July 2021
The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies, moved online for the first time in its 15-year history.
14 July 2021
Bicycle Therapeutics today announced that Ionis Pharmaceuticals has exercised its option and entered into an exclusive worldwide license and collaboration agreement.
14 July 2021
Cambridge life science business Adrestia Therapeutics is scaling fast as it accelerates its mission to rebalance disease and restore health.
14 July 2021
The treatment has been created by scientists at Cancer Research UK and Artios, a spin-out it set up in Cambridge to develop the drug which has received £90 million of funding.
06 April 2021
Incubators can give biotech startups the boost they need to get off the ground. Accelerate@Babraham has made Labiotech's top 25 biotech incubators across Europe supporting the next generation of life science startups.